CRISPR-Cas9 gene-editing: can it be used to identify therapeutic targets for ALS?
Genome-wide gene-knockout screens using CRISPR-Cas9 could allow researchers to identify potential drug targets for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.